Nabriva Therapeutics's total assets for Q were $10.58M, a decrease of -56.54% from the previous quarter. NBRVF total liabilities were $26.90M for the fiscal quarter, a -6.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.